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A cluster of three cases of food-borne botulism due 
to Clostridium baratii type F occurred in France in 
August 2015. All cases required respiratory assis-
tance. Consumption of a Bolognese sauce at the same 
restaurant was the likely source of contamination. 
Clostridium baratii was isolated both from stool speci-
mens from the three patients and ground meat used to 
prepare the sauce. This is the second episode reported 
in France caused by this rare pathogen.
Description of the cases
In August 2015, two clinically suspected cases of 
botulism (having both gastrointestinal and neurologi-
cal symptoms such as dysphagia, diplopia or blurred 
vision, and progressive paralysis) occurred within the 
same intensive care unit in France and were reported 
to the French public health authorities. Patients were 
from different households. Both had presented with 
gastrointestinal symptoms two days before hospital 
admission. Electromyography (EMG) showed a presyn-
aptic block and cerebrospinal fluid (CSF) examination 
was normal. Both patients received a botulinum anti-
toxin ABE treatment, four and five days respectively, 
after symptom onset.
One week later, a third clinically suspected case of 
botulism with gastrointestinal symptom onset within 
the same timeframe as the previous two was reported. 
This patient was initially admitted to a local paediat-
ric unit and later transferred to intensive care unit with 
dyspnoea, dysphonia and global muscular weakness. 
He also presented blurred vision and bilateral mydria-
sis. A few days later, he was transferred to the regional 
paediatric intensive care unit because of clinical wors-
ening. Guillain-Barré syndrome was initially suspected 
based on compatible symptoms, elevated CSF protein 
level, and a first EMG that did not show any presynaptic 
block (day 5 after symptom onset). Therefore, he was 
treated with Intravenous immunoglobulin as an atypi-
cal Guillain-Barré syndrome. A second EMG showed 
presynaptic block six days later (day 11 after symp-
tom onset). Because of this late diagnosis and clinical 
improvement, this patient did not receive any botuli-
num antitoxin treatment.
None of the three cases had any gastrointestinal dis-
ease or invasive gastrointestinal procedure before ill-
ness onset.
All patients subsequently developed quadriplegia and 
respiratory failure requiring intubation and respiratory 
assistance between 24 and 48 hours after symptom 
onset. Median length of hospitalisation was 27 days 
(range: 16–38) and mean duration of intubation was 
15.5 days (range: 9–25). All patients recovered.
Epidemiological, food and environmental 
investigation
The patients were not related to each other. The only 
common food item was pasta with Bolognese sauce 
eaten by the three patients on the same day (lunch or 
dinner) at the same restaurant in late August. The mean 
duration from consumption of the suspected meal to 
symptom onset was 32 hours (range: 18–54 hours) and 
neurological symptoms developed between 24 and 72 
hours after consumption of the suspected meal.
One day after the notification of the first two cases 
(clinical suspicion), the implicated restaurant was 
inspected by the district food control authority (DDPP). 
Inspection revealed hygiene deficiencies in food manu-
facturing and storage according to good practice guide-
lines of the national food safety authorities.
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Samples of food at risk for botulism [1] were collected 
and sent to the National Reference Center (NRC) for 
anaerobic bacteria and botulism in Paris (Table). Two 
days later, although no leftover from the implicated 
Bolognese sauce was available, a second collection 
of food samples targeting sauce ingredients was per-
formed (Table).
Laboratory investigation
The NRC evidenced toxicity in the serum samples of 
each patient (mouse bioassay) but could not confirm 
the identification of botulinum toxin type.
In early September, 13 days after symptom onset, C. 
baratii was identified at the NRC in the stool samples of 
the three patients by PCR and culture. Botulinum toxin 
F was recovered from stool samples of two patients.
No neurotoxigenic Clostridium or toxin was identi-
fied in any of the food samples collected during the 
first inspection (conducted one day after the notifica-
tion of the first two cases). However, both frozen and 
defrosted ground meat samples subsequently collected 
were positive for C. baratii but no toxin was detected 
(Table). In addition, all 34 meat samples collected from 
stored samples at the meat producer tested negative 
for C. baratii at the NRC.
Public health measures
One day after the second inspection, the implicated 
restaurant closed for stock renewal and environmental 
cleaning. No other consumers of Bolognese sauce were 
identified and no other botulism case linked to this res-
taurant was further reported despite the fact that the 
local emergency department was alerted by the local 
health authorities.
Trace-back and trace-forward investigation of the con-
taminated meat batch was conducted by the Ministry 
of Agriculture (DGAL) which issued a product recall. 
Although this batch had been distributed to differ-
ent catering facilities since March 2015, no C. baratii-
related botulism case had been reported between 
March and August 2015.
Discussion
Food-borne botulism due to C. baratii type F is rare 
and only a limited number of cases have been reported 
worldwide [1-6].
The three cases reported here presented with severe 
symptoms and rapid progression towards respiratory 
failure and quadriplegia, although of shorter dura-
tion compared with C. botulinum-related botulism [4]. 
These clinical signs are similar to those described for 
type F botulism cases [1-8]. A high level of protein in 
the CSF has also been described with botulism [7,9], 
which could lead to misdiagnosis.
The first two patients received type ABE botulinum 
antitoxin four and five days respectively, after symp-
tom onset. According to scientific advice on type 
F botulism, published by the European Centre for 
Disease Prevention and Control (ECDC), this treatment 
is expected to be ineffective for type F-related cases 
[1]. However, it has to be noted that these first two 
patients had both hospitalisation and intubation dura-
tion shorter than the third patient who did not receive 
any antitoxin. This difference could be due to other 
factors such as age, medical history, toxin amount 
ingested or other treatment.
The investigation identified the ground meat used 
to prepare the sauce as the most probable vehicle 
of C. baratii contamination. However, the ultimate 
source and mode of contamination of the meat remain 
unknown. No further case was identified in France dur-
ing the shelf-life of the contaminated meat despite the 
wide distribution of the product, and the investigation 
of the producer’s stored samples was negative.
No toxin was found in frozen and defrosted ground 
meat but the sauce eaten by the patients was not 
tested. Based on the restaurant inspection results (no 
Table
The National Reference Center for anaerobic bacteria and 
botulism analysis of 21 food samples, France, August 2015
Food item Day of sampling
Presence 
of toxin
Presence of 
Clostridium baratii
Dried cured ham D1 Neg Neg
Anchovies D1 Neg Neg
Pesto D1 Neg Neg
Ocean sauce 
(seafood) D1 Neg Neg
Frozen ground meat D3 Neg  Pos
Curry chicken D3 Neg Neg
Oil D3 Neg Neg
Tomatoes D3 Neg Neg
Onions D3 Neg Neg
Olive oil D3 Neg Neg
Snails D3 Neg Neg
Leeks D3 Neg Neg
Seafood D3 Neg Neg
Defrosted ground 
meat D3 Neg  Pos
Capers D3 Neg Neg
Tortellini D3 Neg Neg
Raviolini D3 Neg Neg
Smoked salmon D3 Neg Neg
Bolognese saucea D3 Neg Neg
Oregano D3 Neg Neg
Basque chicken D3 Neg Neg
Neg: negative; Pos: positive.
a Served after the suspected meal.
D1 represents Day 1, one day after the notification of the first two 
cases.
D3 represents Day 3, three days after the notification of the first 
two cases.
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temperature monitoring of stored preparations) and 
given the known conditions of toxin production, we can 
hypothesise that the botulinum toxin was produced 
during the sauce cooking process or storage. Indeed, 
preparations of a large volume of meat sauce by boil-
ing for more than ten minutes and storage at room tem-
perature for several hours are favourable conditions 
including anaerobiosis and substrate requirement for 
Clostridium growth and toxin production.
Suspected sources of C. baratii botulism reported in 
the literature included tomato meat sauce [5] and meat 
pit pies [6].
These types of food and ways of toxin production are 
not the most common in botulism, which is usually 
associated with home-canned products or dried pork 
products [1]. From 1981 to 2002, only nine cases of C. 
baratii botulism in adults were reported in the United 
States and a food source was implicated in only one 
[4,5,7]. Hypothesis of adult intestinal colonisation 
botulism was considered to explain unknown sources, 
particularly when gastrointestinal factors that can lead 
to alterations of the intestinal gut flora are associated 
[4,7]. Since 2002, cases with unidentified sources have 
been reported in the United States [8,10-12].Finally, 
some of the unidentified sources for type F botulism 
could be due to unusual sources such as meat.
This is the second C. baratii type F botulism outbreak 
in France in less than one year [2,3]. Given that strains 
are centralised at the NRC, we can expect that any new 
case of type F botulism that may occur in the future, 
will be identified and notified. The type F botulism due 
to C. baratii represented an emerging issue in France 
and in Europe. Type F botulism should be suspected 
in rapid onset and severe flaccid paralysis to promptly 
confirm the diagnosis with specific tests and rapidly 
administer appropriate antitoxin as treatment, when 
available. In Europe, the current botulinum antitoxin 
(capable of protecting only against type A, B, E toxins) 
is not appropriate in case of type F botulism, therefore 
the replacement with the heptavalent antitoxin could 
be considered.
Assuming that this type of botulism is emerging, it 
needs to be monitored with caution because investiga-
tions of new cases in France and Europe may bring new 
information about the origin of the contamination by C. 
baratii.
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